Literature DB >> 20711337

Blood Brain Barrier: The Role of GAD Antibodies in Psychiatry.

Atmaram Yarlagadda1, Badalin Helvink, Caroline Chou, Anita H Clayton.   

Abstract

OBJECTIVE: Goal of our case control study was to establish the presence of antibodies to glutamic acid decarboxylase (GAD) in patients with chronic psychotic disorders.
METHODS: Serum levels of GAD antibodies in 12 patients with chronic psychotic disorders (schizophrenia and schizoaffective disorders) and 10 age-matched healthy control subjects were evaluated utilizing enzyme linked immunosorbitent assay (ELISA).
RESULTS: Antibodies to GAD in patients with chronic psychotic disorders have a higher mean than nonpatient control individuals.
CONCLUSION: Our findings provide the first in-vivo evidence of positive GAD antibodies in chronic psychotic disorders and potentially may be used as a screening for these disorders.

Entities:  

Keywords:  GAD antibodies, schizophrenia; blood brain barrier; diabetes mellitus (DM); glutamic acid decarboxylase (GAD); screening tests

Year:  2007        PMID: 20711337      PMCID: PMC2921245     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  8 in total

1.  Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions.

Authors:  A Yarlagadda
Journal:  Med Hypotheses       Date:  2002-02       Impact factor: 1.538

2.  Serum antibodies in epilepsy and seizure-associated disorders.

Authors:  K McKnight; Y Jiang; Y Hart; A Cavey; S Wroe; M Blank; Y Shoenfeld; A Vincent; J Palace; B Lang
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

Review 3.  The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid.

Authors:  L M Levy; M C Dalakas; M K Floeter
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

4.  Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.

Authors:  G R Vreugdenhil; N C Schloot; A Hoorens; C Rongen; D G Pipeleers; W J Melchers; B O Roep; J M Galama
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

5.  Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; David W Volk; Stephen M Eggan; Karoly Mirnics; Joseph N Pierri; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  J Neurosci       Date:  2003-07-16       Impact factor: 6.167

Review 6.  GABA, gamma-hydroxybutyric acid, and neurological disease.

Authors:  C Guin Ting Wong; Teodoro Bottiglieri; O Carter Snead
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

7.  Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies.

Authors:  Gun Frisk; Torsten Tuvemo
Journal:  J Med Virol       Date:  2004-07       Impact factor: 2.327

Review 8.  GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic- and glutamatergic theories of psychosis.

Authors:  H O Kalkman; E Loetscher
Journal:  J Neural Transm (Vienna)       Date:  2003-07       Impact factor: 3.575

  8 in total
  6 in total

1.  Blood brain barrier: the role of pyridoxine.

Authors:  Atmaram Yarlagadda; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2007-08

2.  The blood brain barrier and the role of ratiometric molecular analysis in schizophrenia.

Authors:  Atmaram Yarlagadda; Christiane S Hampe; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2010-12

3.  GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus.

Authors:  Atmaram Yarlagadda; Jerome H Taylor; Christiane S Hampe; Elizabeth Alfson; Anita H Clayton
Journal:  Innov Clin Neurosci       Date:  2011-08

4.  Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.

Authors:  Mario U Manto; Christiane S Hampe; Véronique Rogemond; Jérome Honnorat
Journal:  Orphanet J Rare Dis       Date:  2011-02-04       Impact factor: 4.123

Review 5.  Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy.

Authors:  Mette Richner; Nelson Ferreira; Anete Dudele; Troels S Jensen; Christian B Vaegter; Nádia P Gonçalves
Journal:  Front Neurosci       Date:  2019-01-14       Impact factor: 4.677

Review 6.  The epidemiologic evidence linking autoimmune diseases and psychosis.

Authors:  Michael E Benros; William W Eaton; Preben B Mortensen
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.